Antibody induction and immune response in nasal cavity by third dose of SARS-CoV-2 mRNA vaccination

BACKGROUND: The mucosa serves as the first defence against pathogens and facilitates the surveillance and elimination of symbiotic bacteria by mucosal immunity. Recently, the mRNA vaccine against SARS-CoV-2 has been demonstrated to induce secretory antibodies in the oral and nasal cavities in additi...

Descripción completa

Detalles Bibliográficos
Autores principales: Ishizaka, Aya, Koga, Michiko, Mizutani, Taketoshi, Uraki, Ryuta, Yamayoshi, Seiya, Iwatsuki-Horimoto, Kiyoko, Yamamoto, Shinya, Imai, Masaki, Tsutsumi, Takeya, Suzuki, Yutaka, Kawaoka, Yoshihiro, Yotsuyanagi, Hiroshi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10339591/
https://www.ncbi.nlm.nih.gov/pubmed/37443091
http://dx.doi.org/10.1186/s12985-023-02113-z

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10339591/
https://www.ncbi.nlm.nih.gov/pubmed/37443091
http://dx.doi.org/10.1186/s12985-023-02113-z

Ejemplares similares